Profiles (Publications) December 4, 2014 PUBLICATIONS Barry Blackwell ARTICLES: 1. Blackwell, B.: Why Patients Come to a Casualty Department. Lancet. (1962), 1:369. 2. Blackwell, B.: Acute Leukemia Presenting as a Lump in the Breast. British Journal of Surgery. (1963), 225:769-771. 3. Lehmann, H., Liddell, J., Blackwell, B., O’Connor, D.C., Daws, A.V.: Two Further Serum Pseudocholinesterase Phenotypes as Causes of Suxamethonium Apnoea. British Medical Journal. (1963), 1:1116-1118. 4. Blackwell, B.: Hypertensive Crisis Due to MAOI. Lancet. (1963), 2:849-851. 5. Blackwell, B.: Munchausen at Guy’s. Guy’s Hospital Reports. (1963), 114 (3):257-277. 6. Blackwell, B.: The Management of Barbituate Overdose in Nonspecialized Units. British Journal of Clinical Practice. (1964), 18 (3):135-144. 7. Blackwell, B., Mallett, B.L.: Psychiatric Illness in a Casualty Department. Guy’s Hospital Reports. (1964), 113:123-130. 8. Blackwell, B., Marley, E.: Interaction Between Cheese and MAOI in Rats and Cats. Lancet. (1964), 1:530-531. 9. Blackwell, B., Davis, B.: Psychiatric Aspects of Myclonus Epilepsy. British Journal of Clinical Practice. (1964), 18 (9):513-516. 10. Palmai, G., Blackwell, B.: The Diurnal Pattern of Salivary Flow in Normal and Depressed Patients. British Journal of Psychiatry. (1965), 111:334-338. 11. Blackwell, B., Mabbitt, L.A.: Tyramine in Cheese Related to Hypertensive Crisis after MAOI. Lancet. (1965), 1:938-940. 12. Blackwell, B., Marley, E., Mabbitt, L.A.: Effects of Yeast Extract after MAOI. Lancet. (1965), 1:940-943. 13. Blackwell, B.: The Simplified Management of Barbituate Overdose. International Medical Digest. (1966), 1:41. 1 14. Blackwell, B., Marley, E.: Interactions of Cheese and Its Constituents with MAOI. British Journal of Pharmacology. (1966), 26:142-161. 15. Blackwell, B., Marley, E.: Interactions of Yeast Extracts and Their Constituents with MAOI. British Journal of Pharmacology. (1966), 26:142-161. 16. Palmai, C., Blackwell, B.: The Burgholzi Centenary. Medical History. (1966), 10(3):257-265. 17. Blackwell, B., Marley, E., Price, J., Taylor, D.: Hypertensive Interaction Between MAOI and Foodstuffs. British Journal of Psychiatry. (1967), 113:349-365. 18. Palmai, G., Blackwell, B., Maxwell, A.E., Morgenstern, F.: Patterns of Salivary Flow in Depressive Illness and During Treatment. British Journal of Psychiatry. (1967), 113:1297-1308. 19. Blackwell, B., Marley, E.: Depressor Effects with Sympathomimetic Amines After Blockade of Cardiovascular Receptors. Nature. (1967), 213:840. 20. Blackwell, B., Taylor, D.: An Operational Evaluation of MAOI. Proc. Roy. Soc. Med. (1967), 60:830-833. 21. Blackwell, B., Shephard, M.: Early Evaluation of Psychotropic Drugs in Man. Lancet. (1967), 2:819-822. 22. Blackwell B., Shephard, M.: Prophylactic Lithium: Another Therapeutic Myth? Lancet. (1968), 1:968-971. 23. Samuel, G., Blackwell, B.: MAOI and Cheese: A Process of Discovery. Hospital Medicine. (1968), 2:942-943. 24. Blackwell, B.: Another Amitriptyline Side Effect. Lancet. (1968), 1:426. 25. Blackwell, B.: The Munchausen Syndrome. British Journal of Hospital Medicine. (1968), 1:98-102. 26. Blackwell, B., Goldberg, D.P.: Psychiatric Interviews in General Practice. British Medical Journal. (1968), 4:99-101. (Published also in Practical Psychiatry, British Medical Journal, 1969.) 27. Blackwell, B., Marley, E.: MAOI and Intolerance to Foodstuffs. Bibliotheca. Nutritio et Dieta. (1969), 11:96-110. 28. Blackwell, B.: The Use of Tranquilizers in General Practice. Prescriber’s Journal. (1969), 9:29. 2 29. Blackwell, B., Mabbitt, L.A., Marley, E.: Histamine and Tyramine Content of Yeast Products. Journal of Food Science. (1969), 34:47-51. 30. Blackwell, B.: Why Drugs Don’t Work: Factors Influencing Outcome with Psychotropic Drugs. Medical Counterpoint. (1969), 1:40. 31. Blackwell, B. Walker, K.P.: Possible Pregnancy in General Practice. Practitioner. (1969), 202:691. 32. Blackwell, B.: Lithium: Prophylactic or Panacea? Medical Counterpoint. (1969), 1(8):52-59. 33. Goldberg, D., Blackwell, B.: Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification. British Medical Journal. (1970), 2:439-443. 34. Blackwell, B., Goldberg, D.: The Use of Psychotropic Drugs in General Practice. Update. (1970), 2(7):927. 35. Blackwell, B.: The Use of Drugs in the Management of Depression. Therapeutic Consult. (1970), 2(2). 36. Blackwell, B., Goldberg, D.: The Patient’s Complaint. Medical Counterpoint. (1970), 2(5):28-38. 37. Blackwell, B., Ayd, F.: Problems of Evaluation of a New Antidepressant Drug in Prison Volunteers. Journal of Clinical Pharmacology and New Drugs. (1971), 2(1):19. 38. Blackwell, B., Sternberg, M.: Trial Management in Psychopharmacology: The Roles and Tasks of an Industry Physician. Journal of Clinical Pharmacology and New Drugs. (1971), 2(2):83-90. 39. Goldberg, D.P., Blackwell, B.: The Management of Psychiatric Illness in General Practice. Update. (1971), 3(3):369. 40. Blackwell, B.: The Scientific and Ethical Problems of Psychotropic Drug Research in Prison Volunteers. Psychopharmacology Bulletin. (1971), 7(4):35. 41. Goldberg, D.P., Blackwell, B.: Psychiatry in General Practice: The Diagnostic Interview in General Practice. Update. (1971), 3(3):239-244. 42. Blackwell, B.: How the Physician Can Influence the Cost of Drugs. Therapeutic Consult. (1971), 3(5&6):9. 3 43. Blackwell, B., Lipkin, J.O., Meyer, J.H., Kuzma, R.: Dose Responses and Relationships Between Anticholinergic Activity and Mood with Tricyclic Antidepressants. Psychopharmacologia. (1972), 25:205-217. 44. Blackwell, B.: For the First Time in Man: A Nationwide Survey of Attitudes to Phase I Research Among Industrial and Academic Scientists. Clinical Pharmacology and Therapeutics. (1972), 13:812. 45. Blackwell, B., Bloomfield, S.S., Buncher, C.R.: Demonstration to Medical Students of Placebo Responses and Non-Drug Factors. Lancet. (1972), 1:1279-1282. 46. Blackwell, B.: The Drug Defaulter. Clinical Pharmacology and Therapeutics. (1972), 13:841-848. 47. Evans, W., Gensler, G., Blackwell, B., Galbrecht, C.: The Effects of Antidepressant Drugs on Pain Relief and Mood in the Chronically Ill. Psychosomatics. (1973), 14:214. 48. Blackwell, B.: Psychotropic Drugs in Use Today: The Role of Diazepam in Medical Practice. Journal of the American Medical Association. (1973), 225:1637-1641. 49. Blackwell, B.: Drug Therapy: Patient Compliance. New England Journal of Medicine. (1973), 289:249-252. 50. Kramer, M., Blackwell, B., Roth, T., Wray, M.: Metiapine in Acute Schizophrenic Patients. Current Therapeutic Research. (1973), 15(7):465- 469. 51. Winstead, D., Blackwell, B., Anderson, A., Eilers, M.K.: Diazepam on Demand: Drug Seeking Behavior in Anxious Inpatients. Archives of General Psychiatry. (1974), 30:349-351. 52. Blackwell, B., Wooley, S.C., Whitehead, W.E.: Psychosomatic Illness: A New Treatment Approach. Cincinnati Journal of Medicine. (1974), 55:95-98. 53. Eilers, M.K., Blackwell, B.: Psychiatric Patients’ Impressions of Teaching Conferences. Journal of Psychiatric Nursing and Mental Health Services. (1974), 12(4):5-9. 54. Lerner, R., Blackwell. B,: Psychiatric Patients: The G.P. as a Psychiatric Community Resource. Journal of Community Mental Health. (1975), 11:3. 4 55. Blackwell, B.: Minor Tranquilizers: Use, Misuse or Overuse. Psychosomatics. (1975), 16:28. 56. Blackwell, B.: A Critical Review of Oxazepam: Efficacy and Specificity. Diseases of the Nervous System. (1975), 36:17. 57. Blackwell, B.: Rational Drug Use in the Management of Anxiety. Rational Drug Therapy. (1975), 9:1. 58. Wooley, S.C., Blackwell, B.: A Behavioral Probe into Social Contingencies on a Psychosomatic Ward. Journal of Applied Behavior Analysis. (1975), 8(3):337-339. 59. Blackwell, B., Stolley, P., Buncher, R., Klimt, C., Temple, R., Venn, D., Wardell, W.: Panel 4: Phase IV Investigations. Clinical Pharmacology and Therapeutics. (1975), 18(5, Part 2):635. 60. Kramer, M., Roth, T., Goldstein, S., Ryan, M., Blackwell, B.: A Double-Blind Evaluation of Metiapine in Hospitalized Acute Schizophrenics. Current Therapeutic Research. (1975), 18(6):839-848. 61. Blackwell, B.: What to Do About the Patient Who Won’t Take His Medicine. Consultant. (1975), 15(2):51-56. 62. Whitehead, W.E., Lurie, E., Blackwell, B.: Classical Conditioning of Decreases in Human Systolic Blood Pressure. Journal of Applied Behavior Analysis. (1976), 9(2):153-157 63. Blackwell, B.: Psychosomatic Aspects of Gastrointestinal Complaints. Journal of the Kentucky Medical Association. (1976), 74(1):26-29. 64. Blackwell, B., Hanenson, I., Bloomfield, S., Magenheim, H., Nidich, S., Gartside, R.: Effects of Transcendental Meditation on Blood Pressure: Individual Response Patterns. Lancet. (1976), 1(7953):223. 65. Blackwell, B.: Prevalence and Variability of Disease: Culture, Morbidity, and Effects of Drugs. Clinical Pharmacology and Therapeutics. (1976), 19(5, Part 2):668-674. 66. Winstead, D., Blackwell, B., Eilers, M.K., Anderson, A.: Psychotropic Drug Use in Five City Hospitals. Diseases of the Nervous System. (1976), 37(9):504- 509. 67. Blackwell, B.: Treatment Adherence in Hypertension. American Journal of Pharmacy and the Sciences Supporting Public Health. (1976), 148(3):75-85. 5 68. Blackwell, B.: Treatment Adherence. British Journal of Psychiatry. (1976), 129:513-531. 69. Blackwell, B.: Medical Education: Old Stresses and New Directions. Pharos. (1977), 40(1):26-30. 70. Whitehead, W.E., Blackwell, B: Why Physicians Prescribe Benzodiazepines in Essential Hypertension. Biological Psychiatry.